AbbVie closes $200M Nimble Therapeutics acquisition
AbbVie closes $200M Nimble Therapeutics acquisition
STARTS NOW! Rebel Edge 🏴☠️1pm line up: U.S. crude oil prices are dropping due to weak demand from China and expected higher U.S. production after the election. WTI is notably lower, part of a wider commodity slump. Stocks $TSLA $COIN $ABBV $HOOD Sports Detroit's kicker makes 58… https://t.co/mZXNAn84q8 https://t.co/HBCDrov0gz
Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial
M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more
AbbVie to buy Aliada Therapeutics for $1.4B in cash
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
336BUSD
Lihat miliarder mana yang memiliki investasi ini
Jenis
Common Stock
Menukarkan
NYSE
Kode mata uang
USD
Nama Mata Uang
US Dollar
Nama negara
USA
ISO Negara
US
ADALAH
US00287Y1091
CUSIP
00287Y109
Sektor
Healthcare
Industri
Drug Manufacturers - General
Akhir Tahun Anggaran
December
tanggal IPO
-
Diperbarui Pada
-
Rasio PE
79.48
Rasio PEG
2.58
Nilai buku
3.41
Pembagian Dividen
0
Hasil Dividen
3.73%
Bagi Hasil
2.39
Target Harga Wall Street
204.90
Estimasi EPS Tahun Ini
12.26
Estimasi EPS Tahun Depan
13.85
Perkiraan EPS Kuartal Saat Ini
2.91
Estimasi EPS Kuartal Berikutnya
2.95
Kuartal Terbaru
-
Pendapatan TTM
55,532,998,656
TTM Laba Kotor
39,059,001,344
EBITDA
25,629,999,104
Margin Keuntungan
9.22%
Pengembalian Aset TTM
7.72%
Pengembalian Ekuitas TTM
56.41%
Pendapatan Per Saham TTM
31.397
Pertumbuhan Pendapatan Kuartalan YOY
3.80%
Eps TTM yang diencerkan
2.39
Pertumbuhan Pendapatan Kuartalan YOY
-12.30%
tertinggal PE
79.48
Maju PE
15
Harga Jual TTM
6.0445
Buku Harga MRQ
55.7036
Pendapatan Nilai Perusahaan
7
EBITDA Nilai Perusahaan
43
85.87
4.08%838.85
1.46%39.62
0.76%315.00
0.36%69.21
0.35%153.59
0.07%318.85
-7.09%139.54
-1.66%90.42
-0.32%104.75
-0.00%